Most Read Articles
Stephen Padilla, 4 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
4 days ago
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Stephen Padilla, 17 hours ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.

Aerobic exercise eases dysmenorrhoea-related pain

12 Jul 2019
Are women just over-exaggerating about dysmenorrhoea being labelled "almost as bad as having heart-attack", or is there some truth to it?

Aerobic exercise appears to ease dysmenorrhoea-related pain and improve quality of life (QoL) and daily functioning, a recent study has found.

Researchers randomly assigned 70 women with primary dysmenorrhoea to receive either a 4-week supervised aerobic training regimen or usual care. The primary outcome was pain, while secondary outcomes were quality of life, sleep and daily functioning.

Compared with the control scenario, the exercise regimen yielded significant improvements in pain intensity (visual analogue scale: mean difference, –4.7, 95 percent CI, –9.3 to –0.09) and pain quality (pain rating index: mean difference, –1.9, –3.8 to –0.04). These effects persisted until 4 and 7 months.

Moreover, improvements in present pain achieved statistical significance by 4 months (mean difference, –0.44, –0.72 to –0.16), which persisted until 7 months.

In terms of secondary outcomes, only the change in pain interference achieved statistical significance after 1 month (mean difference, –1.7, –3.4 to –0.02) and likewise persisted until 4 and 7 months.

In comparison, improvements in the physical (mean difference, 4.0, 1.6–6.4) and mental (mean difference, 2.8, 1.0–4.7) component summaries became significant starting month 4. The same was true for pain severity (mean difference, –2.3, –3.9 to –0.78) and percent pain relief (mean difference, 5.1, 2.0–8.3).

On the other hand, the exercise intervention elicited no significant improvements in sleep relative to usual care across all time points.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 4 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
4 days ago
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Stephen Padilla, 17 hours ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.